intellectual property
Latham & Watkins appoints Lydia Torne as life sciences and IP partner
October 3, 2025Latham & Watkins, intellectual property
Appointment brings specialist healthcare IP commercialisation expertise to the firm Latham & Watkins has appointed Lydia Torne as a partner …
Counterfeit drugs – countering the lies
February 4, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Counterfeit drugs, IP, counterfeit medicines, falsified medicines, intellectual property, law, legal, patent
As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit …
Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows
October 17, 2018Research and Development AMR, IP, intellectual property, patents
Fewer patents are being filed for point-of-care diagnostic technologies aimed at tackling infectious diseases and antimicrobial resistance (AMR), according to …
Health innovation system is broken and failing patients, new report argues
October 15, 2018Sales and Marketing IP, industry, intellectual property, priofit, research
The pharmaceutical industry is incentivised to set high prices and deliver short-term returns to shareholders, rather than focusing on riskier, …
Irish trade lobby warns EU amendments could threaten pharma industry in Ireland, critics contest
August 6, 2018Sales and Marketing EU, IPHA, Ireland, biosimilars, generics, intellectual property, trade lobby
The Irish Pharmaceutical Healthcare Association (IPHA) has warned that changes to existing intellectual property legislation could threaten innovation and deter …
UK second in global innovation index
September 18, 2015Medical Communications, Research and Development Global Innovation Index, World Intellectual Property Organisation, innovation, intellectual property, patents, wipo
The UK – along with Switzerland, Sweden, the Netherlands and the US – is in the world’s five most innovative …
The biggest side-effect of making medicine
September 16, 2015Research and Development evergreening, intellectual property, patent
International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people …
India’s Nexavar patent ruling disturbs pharma
March 12, 2012Sales and Marketing India, emerging markets, intellectual property, patents
India is to allow Bayer’s cancer treatment Nexavar to be subject to a compulsory licence, allowing a generic firm to …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
